How many studies have been conducted on Monensin?

BiohacksAI has indexed 300 PubMed studies on Monensin, including 14 randomized controlled trials (RCTs). 7% of studies involve human subjects.

What are the main research areas for Monensin?

The primary research domains for Monensin are 🔬 Oncology, 🫁 Liver & Detox, 🧠 Focus & Attention. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Monensin

An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. It does not interfere with hosts' development of acquired immunity to the majority of coccidial species. Monensin is a sodium and proton selective ionophore and is widely used as such in biochemical studies.

300+ PubMed studies analyzed · 14 RCTs · Evidence Score: 39.8

Research Domains

Monensin has been studied across 17 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🧠 Focus & Attention, ⚡ Energy & Fatigue, 🔥 Metabolic. The primary research focus is 🔬 Oncology with 9% of studies addressing this area.

Loading evidence profile...

This evidence profile for Monensin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.